ACTRN12615000096550已完成不适用
Comparison of nebulized fluticasone propionate to systemic steroids in the management of childhood asthma attack
Safa Baris0 个研究点目标入组 100 人开始时间: 2015年2月4日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 1 Years 至 16 Years（—）
- 性别
- All
入选标准
- •Asthma attack patients who have pulmonary index score between 6 and 12 and/or peak expiratory flow of 60-80% predicted after three doses of nebulized salbutamol at Emergency Room (ER).
排除标准
- •children with concomitant cardiopulmonary disease, systemic CS use during the last 2 weeks prior to the exacerbation, admission to hospital (including patients requiring intense effort to breath, altered state of consciousness, bradycardia, room air oxygen saturation of less than 88%)
研究者
相似试验
进行中（未招募）
1 期
A Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in the Treatment of Seasonal allergiesEUCTR2015-004885-27-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd936
进行中（未招募）
1 期
Efficacy of Fluticasone Propionate associated With Salmeterol underwent allogeneic hematopoietic stem cell transplantatioBronchiolitis Obliterative Syndrome after hematopoietic stem cell transplantation (HSCT)..EUCTR2020-003010-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)243
进行中（未招募）
1 期
Clinical assessment of fluticasone propionate/ salmeterol xinafoate HFA MDI in 6-month to 4-year-old Japanese patients with bronchial asthmaMedDRA version: 19.0Level: LLTClassification code 10003555Term: Asthma bronchialSystem Organ Class: 100000004855bronchial asthmaEUCTR2016-003479-22-Outside-EU/EEAGlaxoSmithKline Research and development Ltd370
进行中（未招募）
1 期
A Comparison of Fluticasone Furoate Nasal Spray (FFNS) versus OralFexofenadine in the Treatment of Seasonal Allergies.Seasonal Allergic RhinitisEUCTR2015-004873-34-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd680
已完成
4 期
Comparative efficacy of daily inhaled fluticasone propionate and episodic inhaled combined salmeterol/fluticasone propionate in children with recurrent wheezingrecurrent wheezingEfficacy,Daily,Episodic,Inhaled corticosteroids,Recurrent wheezingTCTR20180614002Queen Sirikit National Institute of Child Health72